Covid-19 vaccine approved in India

Biocon’s Covid-19  Itolizumab gets regulatory approved in India. The drug could be used on coronavirus infected patients suffering  from moderate to severe respiratory distress..

According to Kiran Mazumdar-Shaw,  biopharmaceutical company’s  chairperson, “ the randomised control trial indicated that all the patients with Itolizuamb responded positively and recovered.

The clinical studies involving the drug are being closely watched as nations look for treatments for the disease that has infected  over 820,000 people and killed over  22, 000 in India.

The drug cost £80 per vial and the entire course will cost £320.